- Home
- CHWY vs ICLR Comparison
CHWY vs ICLR Comparison
Compare CHWY & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHWY | ICLR |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 14.3B |
| IPO Year | 2019 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CHWY | ICLR |
|---|---|---|
| Price | $33.48 | $185.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 14 |
| Target Price | $45.29 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 6.1M | 987.2K |
| Earning Date | 12-10-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.35 | ★ 7.47 |
| Revenue | ★ $12,345,235,000.00 | $8,102,602,000.00 |
| Revenue This Year | $8.37 | N/A |
| Revenue Next Year | $7.82 | $0.76 |
| P/E Ratio | $95.82 | ★ $24.86 |
| Revenue Growth | ★ 9.17 | N/A |
| 52 Week Low | $29.83 | $125.10 |
| 52 Week High | $48.62 | $228.29 |
Technical Indicators
Market Signals| Indicator | CHWY | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 44.82 | 62.18 |
| Support Level | $32.96 | $174.13 |
| Resistance Level | $35.09 | $191.15 |
| Average True Range (ATR) | 1.17 | 8.46 |
| MACD | 0.10 | 2.87 |
| Stochastic Oscillator | 59.11 | 85.77 |
Price Performance
Historical ComparisonAbout CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.